InvestorsHub Logo
Followers 520
Posts 40228
Boards Moderated 21
Alias Born 09/16/2007

Re: None

Wednesday, 07/13/2011 12:20:59 PM

Wednesday, July 13, 2011 12:20:59 PM

Post# of 63
DATATRAK Signs Multi-Year Consulting Agreement
Datatrak Intl (QX) (USOTC:DATA)
Intraday Stock Chart

Today : Wednesday 13 July 2011
Click Here for more Datatrak Intl (QX) Charts.

DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the award of a multi-year consulting agreement with an existing global biopharmaceutical client to provide clinical data management and trial design services. The award of this contract solidifies DATATRAK's Clinical and Consulting Services (DCCS™) offering and is the impetus behind the Company's expansion into the Research Triangle Park (RTP) area in North Carolina under the direction of Dr. Bill Gluck.

"Our ability to positively impact our clients' study performance is evidenced by the award of this consulting agreement," stated Dr. Bill Gluck, DATATRAK's Vice President of Clinical and Consulting Services. "The benefits of DATATRAK's unified approach to product and service delivery are being recognized across pharma of all sizes, and we are excited that our growth into the RTP area allows us to better serve our customers."

About DATATRAK International, Inc.

DATATRAK International is a worldwide technology and services company delivering eClinical solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services™ group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE™ software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Phase I - Phase IV drug and devices studies in multiple languages throughout the world. DATATRAK has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina. For more information, visit http://www.datatrak.net.

Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain of the factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's quarterly report filed with the OTCQX Market announcing its results for the three-month period ending March 31, 2011. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.

SOURCE DATATRAK International, Inc.